FIELD: medicine.
SUBSTANCE: to assess the clinical course of chronic glomerulonephritis, DNA is recovered from peripheral venous blood of patients with chronic glomerulonephritis. If 4257AA genotype of IL-13 gene is observed, probable formation of severe arterial hypertension and high level of average daily proteinuria during disease are concluded. If detecting 4257A allele of IL-13 gene, the course of chronic glomerulonephritis with moderate proteinuria is probable.
EFFECT: method allows predicting the clinical course of chronic glomerulonephritis within the shortest possible period of time and determining therapeutic strategy for said disease.
3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSMENT OF RENAL SURVIVAL RATE IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS BY INTERLEUKIN GENE POLYMORPHISM VALUES | 2009 |
|
RU2431149C2 |
METHOD FOR PREDICTION OF RENAL SURVIVAL IN PATIENTS SUFFERING CHRONIC GLOMERULONEPHRITIS | 2011 |
|
RU2456606C1 |
METHOD FOR ESTIMATING CLINICAL EFFECTIVENESS IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS | 2011 |
|
RU2473088C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPMENT OF CHRONIC CALCULOUS CHOLECYSTITIS IN MALES | 2015 |
|
RU2598749C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING DAIBETIC RETINOPATHY ACCOMPANYING TYPE 2 DIABETES MELLITUS IN YAKUTS | 2011 |
|
RU2465598C1 |
METHOD FOR PREDICTING CLINICAL COURSE OF CHRONIC CARDIAC FAILURE IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2014 |
|
RU2545899C1 |
METHOD FOR EARLY PREDICTION OF THE RISK OF DEVELOPMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 1 DIABETES MELLITUS | 2022 |
|
RU2793531C1 |
METHOD FOR PREDICTION OF RISK OF THROMBOCYTOPENIA DEVELOPMENT ACCOMPANYING CLINICAL COURSE OF CHRONIC LYMPHATIC LEUKAEMIA | 2012 |
|
RU2508543C1 |
METHOD FOR PREDICTION OF RISK OF CHRONIC CALCULOUS CHOLECYSTITIS IN WOMEN | 2015 |
|
RU2592206C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE AND TREATMENT EFFICACY OF TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2533286C1 |
Authors
Dates
2010-06-27—Published
2009-04-21—Filed